Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative corticosteroids before rectal cancer surgery
IRCT20241122063798N1Phase 3Completed
- Sponsor
- Iran University of Medical Sciences
- Start
- Jun 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial of dexamethasone and methylprednisolone in rectal cancer (3 arms), sponsored by Iran University of Medical Sciences. Primary endpoints: Interleukin-6 and C-reactive protein. Started Jun 2025; status: completed.
02
Drugs
dexamethasonemethylprednisolone
03
Conditions
rectal cancer
Beyond the preview
Go deeper on IRCT20241122063798N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241122063798N1.